In “America-First Regeneration,” AI Integration and Manufacturing Innovation Will Be Market Winners

New PitchBook report, outlines how upcoming U.S. tariff policies are set to reshape biotech and pharma investment priorities. The analysis anticipates increased focus on domestic manufacturing and AI-enabled R&D platforms. While large pharmaceutical companies may deprioritize M&A in the short...
Exclusive

Ongoing Study Insight: Health Basket Committee’s Fear of Death Biases Decisions Toward Life-Extending Treatments

A new ethnographic preliminary insight from an ongoing study by Dr. Yael Assor delves into the Israeli Public Committee for the Enhancement of the Health Basket (PNAC) and its decision-making biases. Her research uncovers a fundamental yet rarely acknowledged tendency:...

Google’s AI Co-Scientist: The New Research Partner for Biotech Scientists

Google's AI Co-Scientist is revolutionizing biomedical research by generating and validating groundbreaking hypotheses. Using advanced AI models, it assists scientists in drug repurposing, target discovery, and understanding antimicrobial resistance. The system refines research proposals through self-improving mechanisms, helping to accelerate...

AI Revolutionizes Breast Cancer Screening: New Study Shows Increased Detection Rates and Reduced Workload

The first randomised controlled trial investigating the use of AI in mammography screening shows that AI-supported mammography increased cancer detection by 29% while cutting workload by 44.2%. Early screening data suggests AI enables earlier detection of small, lymph-node negative cancers....

Analysis of Israel’s 2025 Health Basket Budget: Nearly Half Allocated to Cancer Treatments and RSV Vaccine Funding

An in-depth analysis of Israel’s 2025 health basket reveals how the 650 million NIS budget is allocated, with nearly half directed toward cancer treatments and vaccines. Which patient groups received the highest funding per year? And does the Israeli health...

Owkin Doses First Patient in AI-Driven Oncology Drug Development

Two weeks after announcing Owkin K1.0 Turbigo, a cutting-edge operating system to create the first Artificial General Intelligence (AGI) for biology, Owkin achieves a major milestone in AI-driven drug discovery with OKN4395’s first-in-human trial...

Can AI Healthcare Startups Compete with Tech Giants?

Big Tech’s embedding of AI-driven functionalities across healthcare segments poses a serious challenge for startups. Armed with vast resources and data, giants like Alphabet and Apple set high barriers. The question remains: can startups innovate and survive in this competitive...

Trump’s Return: Challenges and Opportunities for Biotech

Regulatory uncertainty disrupts progress, while merger-friendly policies create opportunities for growth; the industry's global ties face new challenges.Regulatory Uncertainty Meets Economic Promise...

An Alarming Shift:Cancer Rates Rising Among Women

Recent Data Shows Rising Cancer Rates in Women Aged 50-64, Surpassing Those in Men; Mortality Rates Decline Overall; Reported by the American Cancer Society...

Riding the Patent Cliff: How Pharma Giants are Navigating the Sea of Expiring Blockbusters

Facing losses of up to $35 billion annually from expiring patents, pharmaceutical leaders Bristol Myers Squibb, Pfizer, and Merck revealed their strategies at the 2025 J.P. Morgan Healthcare Conference. With a focus on pipeline innovation, strategic acquisitions, and operational efficiency,...

Patients’ “Nightmare” Has Become the Biggest Obstacle to AI in Health Services in Israel

Every patient in Israel faces the bureaucratic nightmare of inconsistent medical records between hospitals and HMOs. This issue is now the main obstacle to AI integration in healthcare. In a presentation by the Ministry of Health to the Knesset’s Health...

Andreessen Horowitz and Eli Lilly Launch $500 Million First-of-Its-Kind Biotech Venture Fund

A unique partnering between a16z and Eli Lilly aims to redefine biotech innovation by fostering early-stage ecosystems through a $500 million venture fund....

EndoStream Medical Acquired by Kaneka Corporation for $100 Million

EndoStream Medical Ltd., an Israeli startup specializing in neurovascular implants, has been acquired by Japan's Kaneka Corporation for $100 million. The deal includes EndoStream's flagship device, Nautilus™, designed for the treatment of cerebral aneurysms. Kaneka forecasts global sales of $140...

Despite the War: Israel’s Biotechnology Investment Landscape Shows Resilience and Innovation in 2024

Israel's health-tech sector secured $1.2 billion in funding in 2024, with digital health leading at $545 million. Major investors such as OrbiMed and OurCrowd drive innovation across biopharma, medical devices, and AI. Despite challenges for early-stage startups, the ecosystem is...
Image by fernando zhiminaicela from Pixabay

Who Will Reign Supreme in Pharma at 2025?

As the biopharma sector gears up for a record-breaking $1 trillion in revenue, Evaluate's analysts forecasts the major players and blockbuster drugs leading the charge. Roche retains its crown as the top drug maker by prescription sales, while Merck’s Keytruda...
Load More
Interesting Read

In “America-First Regeneration,” AI Integration and Manufacturing Innovation Will Be Market Winners

New PitchBook report, outlines how upcoming U.S. tariff policies are set to reshape biotech and pharma investment priorities. The analysis anticipates increased focus on domestic manufacturing and AI-enabled R&D platforms. While large pharmaceutical companies may deprioritize M&A in the short...
Exclusive

Ongoing Study Insight: Health Basket Committee’s Fear of Death Biases Decisions Toward Life-Extending Treatments

A new ethnographic preliminary insight from an ongoing study by Dr. Yael Assor delves into the Israeli Public Committee for the Enhancement of the Health Basket (PNAC) and its decision-making biases. Her research uncovers a fundamental yet rarely acknowledged tendency:...

Google’s AI Co-Scientist: The New Research Partner for Biotech Scientists

Google's AI Co-Scientist is revolutionizing biomedical research by generating and validating groundbreaking hypotheses. Using advanced AI models, it assists scientists in drug repurposing, target discovery, and understanding antimicrobial resistance. The system refines research proposals through self-improving mechanisms, helping to accelerate...

AI Revolutionizes Breast Cancer Screening: New Study Shows Increased Detection Rates and Reduced Workload

The first randomised controlled trial investigating the use of AI in mammography screening shows that AI-supported mammography increased cancer detection by 29% while cutting workload by 44.2%. Early screening data suggests AI enables earlier detection of small, lymph-node negative cancers....

Analysis of Israel’s 2025 Health Basket Budget: Nearly Half Allocated to Cancer Treatments and RSV Vaccine Funding

An in-depth analysis of Israel’s 2025 health basket reveals how the 650 million NIS budget is allocated, with nearly half directed toward cancer treatments and vaccines. Which patient groups received the highest funding per year? And does the Israeli health...

Owkin Doses First Patient in AI-Driven Oncology Drug Development

Two weeks after announcing Owkin K1.0 Turbigo, a cutting-edge operating system to create the first Artificial General Intelligence (AGI) for biology, Owkin achieves a major milestone in AI-driven drug discovery with OKN4395’s first-in-human trial...

Can AI Healthcare Startups Compete with Tech Giants?

Big Tech’s embedding of AI-driven functionalities across healthcare segments poses a serious challenge for startups. Armed with vast resources and data, giants like Alphabet and Apple set high barriers. The question remains: can startups innovate and survive in this competitive...

Trump’s Return: Challenges and Opportunities for Biotech

Regulatory uncertainty disrupts progress, while merger-friendly policies create opportunities for growth; the industry's global ties face new challenges.Regulatory Uncertainty Meets Economic Promise...

An Alarming Shift:Cancer Rates Rising Among Women

Recent Data Shows Rising Cancer Rates in Women Aged 50-64, Surpassing Those in Men; Mortality Rates Decline Overall; Reported by the American Cancer Society...

Riding the Patent Cliff: How Pharma Giants are Navigating the Sea of Expiring Blockbusters

Facing losses of up to $35 billion annually from expiring patents, pharmaceutical leaders Bristol Myers Squibb, Pfizer, and Merck revealed their strategies at the 2025 J.P. Morgan Healthcare Conference. With a focus on pipeline innovation, strategic acquisitions, and operational efficiency,...
Load More

© [2025] TheMed.co.il. All rights reserved.